2001
DOI: 10.1006/jsre.2000.6030
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Applications of Magnetic Drug Targeting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
418
0
4

Year Published

2004
2004
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 785 publications
(443 citation statements)
references
References 24 publications
2
418
0
4
Order By: Relevance
“…Once the drug carrier is concentrated at the target, the drug can be released either via enzymatic activity or changes in physiological conditions, such as pH or temperature , and be taken up by the tumor cells. An overview of the clinical applications of magnetic drug targeting was given by Lubbe et al (2001). Larger particles with dimension> lm, comprising agglomerates of superparamagnetic particles, were shown to be more effective in withstanding flow dynamics within the circulatory system.…”
Section: Drug Targetingmentioning
confidence: 99%
“…Once the drug carrier is concentrated at the target, the drug can be released either via enzymatic activity or changes in physiological conditions, such as pH or temperature , and be taken up by the tumor cells. An overview of the clinical applications of magnetic drug targeting was given by Lubbe et al (2001). Larger particles with dimension> lm, comprising agglomerates of superparamagnetic particles, were shown to be more effective in withstanding flow dynamics within the circulatory system.…”
Section: Drug Targetingmentioning
confidence: 99%
“…[620] A magnetic field strength of 0.8 was provided in tumors located near the body surface by using properly arranged permanent magnets to concentrate the resulting ferrofluid in the target regions. [621] In addition to all these developments, exploiting the stimuli-responsive systems allows for tailored release profiles with excellent spatial, temporal, and dosage control (Figure 35). Specifically, by recognizing their microenvironment, they enable on-demand processes (also termed as "switch on/off") and react in a dynamic way, which in turn mimic the responsiveness of living organisms.…”
Section: Magnetic Drug Targetingmentioning
confidence: 99%
“…[668,670] One problem is associated with the considerable hydrodynamic force generated by high blood velocities in the vascular system [668] which is the only significant force that should be overcome to prevent adverse hydrodynamic conditions on accumulation of MNPs at the target zone. [671] Even in the most favorable situation that the magnetic source is located close to the target zone, which is rarely the case, [621] the drag force exerted on the particles by the blood flow may dominate the magnetic force. [672] Another important problem is the inherent tendency of magnetic fields to be homogeneous over the target zone, which results in very small magnetic field gradients that makes it difficult to collect appreciable amounts of drugs in that region.…”
Section: Implant Assisted Magnetic Drug Targeting (Ia-mdt)mentioning
confidence: 99%
“…This is not necessarily an advantage for magnetophoretic-based applications such as drug delivery. 54 Thus, one might want to create a system which can be strongly magnetized on the one hand, and be spatially isotropic on the other.…”
Section: Introductionmentioning
confidence: 99%